@ItIsMikeFitz Afrezza will probably remain the latest and greatest breakthrough in insulin from here on out. Big Pharma is no longer in the game of insulin therapies, only weight loss, following the money.
I just wish big pharma would stop showering healthcare with rebates, cornering market
The FDA has officially released MannKind from the long standing Afrezza pulmonary malignancy postmarketing requirement that dated back to the original 2014 approval.
Now the FDA says it’s no longer required.
Will this mean the removal of the black box warning? It should!
#Afrezza#T1D#Diabetes
Parents and kids, we’re likely only a couple weeks away from FDA approval of Afrezza for under 18. Yes, inhalable insulin, but that’s not even the greatest part. Join the Fb Afrezza users group for more life changing info, that no Endo will tell you.
#Afrezza
Just another angle I hadn’t shared. Afrezza provides me with the highest quality of T1D life! Diabetes management is still on my mind 24/7, but it’s different with Afrezza. With Afrezza, I am in control. I have the power to Take Control of my diabetes.
@ItIsMikeFitz Afrezza will probably remain the latest and greatest breakthrough in insulin from here on out. Big Pharma is no longer in the game of insulin therapies, only weight loss, following the money.
I just wish big pharma would stop showering healthcare with rebates, cornering market